Kimia Biosciences Ltd — Important, 29-12-2025: Company Update

KIMIA BIOSCIENCES has approved the appointment of Mr. Kaku Vijaya Shekhar Reddy as an Additional Director (Executive Director), pending shareholder approval. Mr. Reddy is a highly experienced pharmaceutical professional with over 40 years in Active Pharmaceutical Ingredients (API) manufacturing. His extensive expertise spans operations management, project execution, regulatory compliance, and business strategy. This appointment brings significant leadership depth to the company, aiming to enhance strategic direction and operational capabilities, particularly within the crucial API sector, benefiting shareholders.